These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Metabolic tumor volumes by [18F]-fluorodeoxyglucose PET/CT correlate with occult metastasis in oral squamous cell carcinoma of the tongue. Chung MK; Jeong HS; Son YI; So YK; Park GY; Choi JY; Hyun SH; Kim HJ; Ko YH; Baek CH Ann Surg Oncol; 2009 Nov; 16(11):3111-7. PubMed ID: 19609618 [TBL] [Abstract][Full Text] [Related]
24. Long-term survival analysis of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA levels. Wang WY; Twu CW; Chen HH; Jiang RS; Wu CT; Liang KL; Shih YT; Chen CC; Lin PJ; Liu YC; Lin JC Cancer; 2013 Mar; 119(5):963-70. PubMed ID: 23065693 [TBL] [Abstract][Full Text] [Related]
25. Correlation of Epstein-Barr virus DNA in cell-free plasma, functional imaging and clinical course in locally advanced nasopharyngeal cancer: a pilot study. Mäkitie AA; Reis PP; Irish J; Zhang T; Chin SF; Chen X; Marriott C; Keller A; Perez-Ordonez B; Kamel-Reid S; Siu LL Head Neck; 2004 Sep; 26(9):815-22. PubMed ID: 15350028 [TBL] [Abstract][Full Text] [Related]
26. Stage II recurrent nasopharyngeal carcinoma: Prognostic significance of retropharyngeal nodal metastasis, parapharyngeal invasion, and carotid encasement. Chan JYW; Wong STS; Wei WI Head Neck; 2018 Jan; 40(1):103-110. PubMed ID: 29083514 [TBL] [Abstract][Full Text] [Related]
27. Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT. Comoretto M; Balestreri L; Borsatti E; Cimitan M; Franchin G; Lise M Radiology; 2008 Oct; 249(1):203-11. PubMed ID: 18710963 [TBL] [Abstract][Full Text] [Related]
28. Selectively recommend Chen C; Xu T; Qiu X; Xie S; You Z; Hu Y; Zheng Y; Liang Z; Huang C; Chen T; Li L; Liu J; Fei Z Radiat Oncol; 2021 Nov; 16(1):229. PubMed ID: 34838075 [TBL] [Abstract][Full Text] [Related]
29. Early restaging whole-body (18)F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma. Yen RF; Chen TH; Ting LL; Tzen KY; Pan MH; Hong RL Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1152-9. PubMed ID: 15965687 [TBL] [Abstract][Full Text] [Related]
30. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma. Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452 [TBL] [Abstract][Full Text] [Related]
31. [Quantitative analysis of plasma Epstein-Barr virus (EBV) DNA for monitoring of recurrence and metastasis in nasopharyngeal carcinoma patients after radiotherapy]. Li YH; Shao JY; Zhao MQ; Gao HY; Li LR; Guan ZZ; Zeng YX Ai Zheng; 2003 Jun; 22(6):645-8. PubMed ID: 12948418 [TBL] [Abstract][Full Text] [Related]
32. Prospective study of prognostic value of Raf kinase inhibitory protein and pretreatment plasma Epstein-Barr virus DNA for distant metastasis in locoregionally advanced nasopharyngeal carcinoma. Li SW; Wang H; Xiang YQ; Zhang HB; Lv X; Xia WX; Zeng MS; Mai HQ; Hong MH; Guo X Head Neck; 2013 Apr; 35(4):579-91. PubMed ID: 22605662 [TBL] [Abstract][Full Text] [Related]
33. Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma. Ma BB; Chan AT Expert Rev Anticancer Ther; 2006 Mar; 6(3):383-94. PubMed ID: 16503855 [TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of parapharyngeal space venous plexus and marrow involvement: potential landmarks of dissemination for stage I-III nasopharyngeal carcinoma. Cheng SH; Tsai SY; Yen KL; Jian JJ; Feng AC; Chan KY; Hong CF; Chu NM; Lin YC; Lin CY; Tan TD; Hsieh CY; Chong V; Huang AT Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):456-65. PubMed ID: 15667967 [TBL] [Abstract][Full Text] [Related]
35. Primary tumor volume calculation as a predictive factor of prognosis in nasopharyngeal carcinoma. Lee CC; Chu ST; Ho HC; Lee CC; Hung SK Acta Otolaryngol; 2008 Jan; 128(1):93-7. PubMed ID: 17851945 [TBL] [Abstract][Full Text] [Related]
36. Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma. Leung SF; Zee B; Ma BB; Hui EP; Mo F; Lai M; Chan KC; Chan LY; Kwan WH; Lo YM; Chan AT J Clin Oncol; 2006 Dec; 24(34):5414-8. PubMed ID: 17135642 [TBL] [Abstract][Full Text] [Related]
37. Extension of local disease in nasopharyngeal carcinoma detected by magnetic resonance imaging: improvement of clinical target volume delineation. Liang SB; Sun Y; Liu LZ; Chen Y; Chen L; Mao YP; Tang LL; Tian L; Lin AH; Liu MZ; Li L; Ma J Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):742-50. PubMed ID: 19251378 [TBL] [Abstract][Full Text] [Related]
38. Primary tumor volume of nasopharyngeal carcinoma: significance for survival. Lee CC; Ho HC; Lee MS; Hsiao SH; Hwang JH; Hung SK; Chou P Auris Nasus Larynx; 2008 Sep; 35(3):376-80. PubMed ID: 18249078 [TBL] [Abstract][Full Text] [Related]
39. Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 53 patients and prognostic factors. Hao SP; Tsang NM; Chang KP; Hsu YS; Chen CK; Fang KH Acta Otolaryngol; 2008 Apr; 128(4):473-81. PubMed ID: 18368585 [TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Mutirangura A; Pornthanakasem W; Theamboonlers A; Sriuranpong V; Lertsanguansinchi P; Yenrudi S; Voravud N; Supiyaphun P; Poovorawan Y Clin Cancer Res; 1998 Mar; 4(3):665-9. PubMed ID: 9533535 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]